In 2020, cancer diagnoses will thrust nearly 2 million Americans into the often bewildering world of treatments and clinical trials. TrialJectory aims to help. The service uses AI to read through thousands of clinical trials and extract information about the sorts of patients the researchers are looking for. Its algorithm then matches users with the clinical trials—like the one a patient found for her Stage IV metastatic breast cancer—based on the users’ responses to a series of questions about themselves and their disease progression. Since launching in 2018, TrialJectory’s researchers have expanded the system to cover more types of cancer, adding lung cancers this summer. —Alejandro de la Garza
More Must-Reads From TIME
- Alison Roman Won't Sugarcoat It
- If Donald Trump Is Indicted, Here's What Would Happen Next in the Process
- All of the Other Major Investigations Into Donald Trump
- Who Should Be on the 2023 TIME100? Vote Now
- The Case for Betting on Succession's Tom Wambsgans
- Postmaster General Louis DeJoy's Surprising Second Act
- In This Texas County, There's No Such Thing as Moving on From COVID-19
- Why Trump's Call to Protest Is Flopping
- Column: Ozempic Exposed the Cracks in the Body Positivity Movement